A/Prof Jeanne Tie is the lower gastrointestinal medical oncologyStudy and treatment of cancer using chemotherapy (chemical drugs). and trials lead at the Peter MacCallum CancerA disease where abnormal cells split without control and spread to other nearby body tissue and/or organs. Cancer cells can also spread to other parts of the body through the bloodstream and lymph systems. Centre and senior research fellow in the Personalised OncologyThe study and treatment of tumours, cancers. Division at the Walter and Eliza Hall Institute of Medical Research. Her translational research focusses on personalising treatment for patients with colorectalTo do with the colon (big bowel) and rectum (the back passage; bum) an operation where the colon (bowel) is cut and joined to an opening (stoma) made in the stomach wall so that stools/waste products (poo) can move through the stoma into a bag on the outside of the body. cancer with prognostic and predictive biomarkers, in particular the clinical applications of circulating tumour DNA (ctDNA). She leads several ctDNA-based randomized clinical trials in colorectal cancer which aim to assessTo measure, look at and learn from. the clinical utility of ctDNA in guiding adjuvant treatment decision.
A/Prof Tie’s clinical trialA study to test new treatments such as drugs, procedures or technologies to see if they work and/or are safe for people. work focusses on evaluating new treatment for patients with colorectal cancer. She serves or has served on the Australasian Gastrointestinal Trials Group (AGITG) Scientific Advisory Committee and Lower GI working party, Cancer Adjudication Committee for the ASPREE (Aspirin in Reducing Events in the Elderly) International study, ESMO (European Society for Medical Oncology) Gastro-Intestinal Tumours Faculty, American Society of Clinical Oncology (ASCO) Education Faculty and ESMO Asia Congress Gastrointestinal Track Co-Chair.
Location
305 Grattan Street, Melbourne VIC, Australia